The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment. Read more here.
Podcast: All Things Cardio-Oncology
Listen to the podcast of the International Cardio-Oncology Society here.
Certification Exam in Cardio-Oncology Knowledge
Apply for the IC-OS Certification Exam in Cardio-Oncology Knowledge here.
IC-OS Board Exam Review Book
Purchase the IC-OS Board Exam Review Book here.
We're excited to announce a new Cardio-Oncology initiative: "Practical Approaches to Cardio-Oncology Care." We invite manuscripts dealing with state-of-the-art management of common clinical cardio-oncology issues and toxicities, e.g., “How to manage pericardial effusions.” As part of a new series, we will offer expedited reviews for rapid processing. See here for details.
Aims and scope
Could your research help reduce toxicities from cancer therapy? Submit your funding proposal to HESI Thrive by April 8, 2024, and help make cancer patient quality of life an active research priority!
Winner of our "Cancer and the heart" manuscript competition
We are delighted to announce the winner of our "Cancer and the heart: Novel insights of biology, diagnosis, and management" manuscript competition, which has been sponsored by ICOS in collaboration with the Thalheimer Center for Cardio-Oncology at the University of Pennsylvania.
Congratulations to Drs. Prince Otchere, Olusola Adekoya, Samuel B. Governor, Naveen Vuppuluri, Akruti Prabhakar, Stella Pak, Oduro Oppong-Nkrumah, Francis Cook, Rudy Bohinc, and Gregory Aune for their winning paper: Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapy.
See the competition collection page for more details.
We offer heartfelt congrats to the winners of the top abstracts at the First International Pediatric Cardio-Oncology Conference. The winners were each presented with a prize from the journal at the conference. The winners, in no particular order, are: Lieke (E.A.M.) Feijen-Allenstein, PhD; Takeshi Tsuda, MD, FACC; Elvira C. van Dalen, MD, PhD; and Christina Yang, MD.
For this Cardio-Oncology article collection, we welcome submissions examining cardiotoxicity caused by chemotherapy, radiotherapy, molecular-targeted agents, and immune-modulating agents. Manuscripts investigating cardiotoxicity related to novel cancer treatments will be highly appreciated. See here for more details.
About the society
Cardio-Oncology is the official journal of the International Cardio-Oncology Society (ICOS). The society brings together cardio-oncologists from around the world with the aim of reducing cardiovascular disease in cancer patients and thereby saving patients' lives. For more information about this important work, please visit the ICOS website.
Members of ICOS currently receive a 25% discount on submissions. The discount should be requested using the ICOS discount code during the submission process. ICOS members unsure of the code for society members, should contact the Publishing Editor.
Peer Review Taxonomy
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: None
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.
Get to know our Section Editors
Thomas D. Ryan, MD, PhD
Thomas D. Ryan, MD, PhD, FAAP, FACC, FAHA is the Director of Clinical Operations in the Cardiomyopathy and Heart Failure Program, and the founding Co-Director of the Cardio-Oncology Program at Cincinnati Children’s Hospital Medical Center (CCHMC). He is also an Associate Professor of Pediatrics-Clinical at the University of Cincinnati College of Medicine.
Dr. Ryan graduated magna cum laude from Wichita State University with a BS in Biological Sciences and earned both an MD and PhD at the University of Alabama School of Medicine/University of Alabama at Birmingham. He completed general pediatrics residency and pediatric cardiology fellowship at CCHMC and was the first graduate of the CCHMC Heart Institute’s Advanced Fellowship in Pediatric Heart Failure, Cardiomyopathy, and Cardiac Transplantation.
Dr. Ryan’s clinical and research interests focus on inherited and acquired cardiomyopathy as well as cardiac transplantation. He has particular emphasis on patients who have developed heart dysfunction because of cancer-related therapies. He has published over 70 manuscripts in peer-reviewed journals and is author of 10 textbook chapters. He was on the founding Leadership Council for the Cardio-Oncology Member Section of the American College of Cardiology and was the first Chair of the Pediatric Working Group. Dr. Ryan serves as Co-Chair of the Institutional Review Board at CCHMC, as well as Section Editor for the journal Cardio-Oncology.
About the Editors
Steven Lipshultz, Editor-in-Chief
Steven E. Lipshultz, MD, FAAP, FAHA is the A. Conger Goodyear Professor and Chair of the Department of Pediatrics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, The State University of New York; the Chief of Service of Pediatrics at Kaleida Health; the Medical Director of Pediatric Services Business Development at John R. Oishei Children’s Hospital; President of UBMD Pediatrics (University at Buffalo Pediatric Associates, Inc.); and a Consultant in Pediatrics and Cardio-Oncology for the Roswell Park Comprehensive Cancer Center.
Joseph Carver, Deputy Editor
Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.
Giorgio Minotti, Deputy Editor
Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.
Annual Journal Metrics
2022 Citation Impact
3.3 - 2-year Impact Factor
0.977 - SNIP (Source Normalized Impact per Paper)
0.790 - SJR (SCImago Journal Rank)
10 days submission to first editorial decision for all manuscripts (Median)
130 days submission to accept (Median)
534 Altmetric mentions
On the blog
06 April 2023
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).